Tenofovir disoproxil Teva 245 mg Норвешка - Норвешки - Statens legemiddelverk

tenofovir disoproxil teva 245 mg

teva pharma b.v. (4) - tenofovirdisoproksilfumarat - tablett, filmdrasjert - 245 mg

Zepatier Европска Унија - Норвешки - EMA (European Medicines Agency)

zepatier

merck sharp & dohme b.v. - elbasvir, grazoprevir - hepatitt c, kronisk - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 og 5. for hepatitt c-virus (hcv) genotype-spesifikk aktivitet, se kapittel 4. 4 og 5.

Abboticin 100 mg/ ml Норвешка - Норвешки - Statens legemiddelverk

abboticin 100 mg/ ml

amdipharm limited - erytromycinetylsuksinat - granulat til mikstur, suspensjon - 100 mg/ ml

Abboticin 40 mg/ ml Норвешка - Норвешки - Statens legemiddelverk

abboticin 40 mg/ ml

amdipharm limited - erytromycinetylsuksinat - granulat til mikstur, suspensjon - 40 mg/ ml

Abboticin 1 g Норвешка - Норвешки - Statens legemiddelverk

abboticin 1 g

amdipharm limited - erytromycinlaktobionat - pulver til infusjonsvæske, oppløsning - 1 g

Abboticin ES 500 mg Норвешка - Норвешки - Statens legemiddelverk

abboticin es 500 mg

amdipharm limited - erytromycinetylsuksinat - tablett, filmdrasjert - 500 mg

Cliovelle 1 mg / 0.5 mg Норвешка - Норвешки - Statens legemiddelverk

cliovelle 1 mg / 0.5 mg

dr. kade pharmazeuyische fabrik gmbh - Østradiolvalerat / noretisteronacetat - tablett - 1 mg / 0.5 mg

Tacforius Европска Унија - Норвешки - EMA (European Medicines Agency)

tacforius

teva b.v. - takrolimusmonohydrat - liver transplantation; kidney transplantation - immunsuppressive - profylakse av transplantasjonsavstøtning hos voksne pasienter med nyre- eller leverallograft. behandling av allograftavvisning resistent mot behandling med andre immunosuppressive legemidler hos voksne pasienter.

Rekambys Европска Унија - Норвешки - EMA (European Medicines Agency)

rekambys

janssen-cilag international nv - rilpivirine - hiv-infeksjoner - antivirale midler til systemisk bruk - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.

Cevenfacta Европска Унија - Норвешки - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemoragika - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.